|
Volumn 14, Issue 6, 1997, Pages 706-712
|
Cellular delivery of nucleoside diphosphates: A prodrug approach
a b c d a,b a |
Author keywords
2' Azido 2' deoxycytidine; 2' Azido 2' deoxyuridine; 2' Azido 2' deoxyuridine 5' diphosphate; Anticancer agent; Phosphorylation of nucleoside analogue; Prodrug; Ribonucleotide reductase
|
Indexed keywords
2' AZIDO 2' DEOXYCYTIDINE 5' DIPHOSPHATE;
2' AZIDO 2' DEOXYURIDINE 5' DIPHOSPHATE;
DEOXYCYTIDINE KINASE;
NUCLEOSIDE ANALOG;
PRODRUG;
RIBONUCLEOTIDE REDUCTASE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CELL GROWTH;
CELL VIABILITY;
CHO CELL;
CYTOTOXICITY;
DRUG ACTIVITY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
NONHUMAN;
PHOSPHORYLATION;
PRIORITY JOURNAL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
AZIDES;
CELL DIVISION;
CELL LINE;
CHO CELLS;
CRICETINAE;
CYTIDINE DIPHOSPHATE;
DEOXYCYTIDINE;
DEOXYCYTIDINE KINASE;
DEOXYURACIL NUCLEOTIDES;
DEOXYURIDINE;
HYDROLYSIS;
PERMEABILITY;
PHOSPHORYLATION;
PRODRUGS;
RIBONUCLEOTIDE REDUCTASES;
TUMOR CELLS, CULTURED;
URIDINE MONOPHOSPHATE;
|
EID: 0030927148
PISSN: 07248741
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1012133902314 Document Type: Article |
Times cited : (9)
|
References (32)
|